{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:34:38Z","timestamp":1792028078597,"version":"4.4.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jfma.2023.04.025","type":"journal-article","created":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:55:15Z","timestamp":1683939315000},"page":"976-985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prevention and management of tuberculosis in solid organ transplantation: A consensus statement of the transplantation society of Taiwan"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9291-2490","authenticated-orcid":false,"given":"Chen-Yuan","family":"Chiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yih","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7492-4191","authenticated-orcid":false,"given":"Yang-Jen","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9733-5899","authenticated-orcid":false,"given":"Wei-Chang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0998-3229","authenticated-orcid":false,"given":"Yih-Jyh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Hsu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin-Hui","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0321-910X","authenticated-orcid":false,"given":"Ming-Che","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chung","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsu-Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3406-366X","authenticated-orcid":false,"given":"Jann-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai-Szu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2023.04.025_bib1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jfma.2023.04.025_bib2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1164\/rccm.202011-4239PP","article-title":"Latent tuberculosis: two centuries of confusion","volume":"204","author":"Behr","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jfma.2023.04.025_bib3","series-title":"Handbook of global tuberculosis control: practices and challenges","first-page":"359","article-title":"Latent infection with Mycobacterium tuberculosis","author":"Chiang","year":"2017"},{"key":"10.1016\/j.jfma.2023.04.025_bib4","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/514993","article-title":"Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management","volume":"27","author":"Singh","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jfma.2023.04.025_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13259","article-title":"Mycobacterium tuberculosis after solid organ transplantation: a review of more than 2000 cases","volume":"32","author":"Abad","year":"2018","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jfma.2023.04.025_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijtb.2019.05.001","article-title":"Tuberculosis in renal transplant recipients: our decade long experience with an opportunistic invader","volume":"67","author":"Eswarappa","year":"2020","journal-title":"Indian J Tubercul"},{"key":"10.1016\/j.jfma.2023.04.025_bib7","first-page":"1471","article-title":"The risk factors for tuberculosis in liver or kidney transplant recipients","author":"Liu","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jfma.2023.04.025_bib8","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1086\/599035","article-title":"Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in RESITRA (Spanish Network of Infection in Transplantation) cohort","volume":"48","author":"Torre-Cisneros","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jfma.2023.04.025_bib9","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1093\/ndt\/gfr156","article-title":"Tuberculosis following kidney transplantation: clinical features and outcome. A French multicentre experience in the last 20 years","volume":"26","author":"Canet","year":"2011","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"10.1016\/j.jfma.2023.04.025_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1399-3062.2009.00475.x","article-title":"Tuberculosis following solid organ transplantation","volume":"12","author":"Lopez de Castilla","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jfma.2023.04.025_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02245-2018","article-title":"Tuberculosis following renal transplantation in England, Wales an Northern Ireland: a national registry-based cohort study","volume":"54","author":"Gupta","year":"2019","journal-title":"Eur Respir J"},{"issue":"s4","key":"10.1016\/j.jfma.2023.04.025_bib12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/ajt.12100","article-title":"Mycobacterium tuberculosis infections in solid organ transplantation","volume":"13","author":"Subramanian","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jfma.2023.04.025_bib13","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1086\/597590","article-title":"Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish society of infectious diseases and clinical microbiology","volume":"48","author":"Aguado","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jfma.2023.04.025_bib14","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1183\/09031936.00000712","article-title":"The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement","volume":"40","author":"Bumbacea","year":"2012","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.jfma.2023.04.025_bib15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1086\/427692","article-title":"Mycobacterium tuberculosis infection in recipients of solid organ transplants","volume":"40","author":"Mu\u00f1oz","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jfma.2023.04.025_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12971","article-title":"Donor derived Mycobacterium tuberculosis infection after solid-organ transplantation: a comprehensive review","volume":"20","author":"Abad","year":"2018","journal-title":"Transpl Infect Dis"},{"issue":"26","key":"10.1016\/j.jfma.2023.04.025_bib17","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jfma.2023.04.025_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.tp.0000168436.76784.45","article-title":"Immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors?","volume":"80","author":"Wong","year":"2005","journal-title":"Transplantation"},{"issue":"Suppl 3","key":"10.1016\/j.jfma.2023.04.025_bib19","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.025_bib20","article-title":"Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients","volume":"1","author":"Hill","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.025_bib21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2215\/CJN.02360311","article-title":"The influence of induction therapy for kidney transplantation after a non-renal transplant","volume":"7","author":"Cassuto","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.jfma.2023.04.025_bib22","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2215\/CJN.13171215","article-title":"Acute rejection rates and graft outcomes according to induction regimen among recipients of kidneys from deceased donors treated with tacrolimus and mycophenolate","volume":"11","author":"Tanriover","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.jfma.2023.04.025_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1399-3062.2006.00147.x","article-title":"Mycobacterium tuberculosis infection following renal transplantation in Taiwan","volume":"8","author":"Chen","year":"2006","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"10.1016\/j.jfma.2023.04.025_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13729","article-title":"Incidence rate of active tuberculosis in solid organ transplant recipients: data from a nationwide population cohort in a high-endemic country","volume":"23","author":"Kwon","year":"2021","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.jfma.2023.04.025_bib25","first-page":"172","article-title":"Rituximab therapy and infection risk in pediatric renal transplant patients","volume":"14","author":"Gulleroglu","year":"2016","journal-title":"Exp Clin Transplant"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.025_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/1319-2442.124459","article-title":"Anti-thymocyte globulin versus basiliximab induction in renal transplant recipients: long-term outcome","volume":"25","author":"Kesiraju","year":"2014","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"2","key":"10.1016\/j.jfma.2023.04.025_bib27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ajt.13052","article-title":"Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety","volume":"15","author":"van den Hoogen","year":"2015","journal-title":"Am J Transpl"},{"issue":"7520","key":"10.1016\/j.jfma.2023.04.025_bib28","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bmj.38569.471007.AE","article-title":"Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data","volume":"331","author":"Webster","year":"2005","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jfma.2023.04.025_bib29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/aor.13551","article-title":"Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity","volume":"44","author":"Bentata","year":"2020","journal-title":"Artif Organs"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.025_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12626","article-title":"Impact of type of calcineurin inhibitor on post-transplant tuberculosis: single-center study from India","volume":"19","author":"Agarwal","year":"2017","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"10.1016\/j.jfma.2023.04.025_bib31","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1399-3062.2012.00737.x","article-title":"Impact of pulmonary and extrapulmonary tuberculosis infection in kidney transplantation: a nationwide population-based study in Taiwan","volume":"14","author":"Ou","year":"2012","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"10.1016\/j.jfma.2023.04.025_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.21037\/atm.2020.01.120","article-title":"Management and prophylaxis of bacterial and mycobacterial infections among lung transplant recipients","volume":"8","author":"Okamoto","year":"2020","journal-title":"Ann Transl Med"},{"issue":"2","key":"10.1016\/j.jfma.2023.04.025_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1600-6143.2003.00337.x","article-title":"Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo\u00a0renal transplant patients","volume":"4","author":"Salvadori","year":"2004","journal-title":"Am J Transplant"},{"issue":"5\u20136","key":"10.1016\/j.jfma.2023.04.025_bib34","first-page":"199","article-title":"Does mycophenolate mofetil increase the incidence of infections in renal transplant recipients?","volume":"31","author":"Prokopenko","year":"2005","journal-title":"Drugs Exp Clin Res"},{"issue":"7","key":"10.1016\/j.jfma.2023.04.025_bib35","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.transproceed.2004.08.015","article-title":"Does mycophenolate mofetil increase the incidence of infections in stable renal transplant recipients initially treated with a two-drug regimen?","volume":"36","author":"Chen","year":"2004","journal-title":"Transpl Proc"},{"issue":"3","key":"10.1016\/j.jfma.2023.04.025_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10096-001-0684-y","article-title":"Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression","volume":"21","author":"Bernabeu-Wittel","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.jfma.2023.04.025_bib37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1590\/S1413-86702006000200011","article-title":"Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?--A mini-review","volume":"10","author":"Song","year":"2006","journal-title":"Braz J Infect Dis"},{"issue":"8","key":"10.1016\/j.jfma.2023.04.025_bib38","first-page":"741","article-title":"Long-term safety of mycophenolate mofetil and cyclosporine: a review","volume":"7","author":"Buell","year":"2008","journal-title":"J Drugs Dermatol JDD"},{"issue":"4","key":"10.1016\/j.jfma.2023.04.025_bib39","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/ndt\/gfh691","article-title":"Tuberculosis in renal transplant recipients on various immunosuppressive regimens","volume":"20","author":"Atasever","year":"2005","journal-title":"Nephrol Dial Transpl"},{"issue":"7","key":"10.1016\/j.jfma.2023.04.025_bib40","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1681\/ASN.2018010009","article-title":"Everolimus with reduced calcineurin inhibitor exposure in renal transplantation","volume":"29","author":"Pascual","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.jfma.2023.04.025_bib41","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1111\/ajt.13235","article-title":"Incidence and risk factors for tuberculosis after liver transplantation in an endemic area: a nationwide population-based matched cohort study","volume":"15","author":"Chen","year":"2015","journal-title":"Am J Transpl"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.025_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0377-1237(09)80047-6","article-title":"Renal transplantation: experience at a single centre","volume":"65","author":"Murty","year":"2009","journal-title":"Med J Armed Forces India"},{"issue":"5","key":"10.1016\/j.jfma.2023.04.025_bib43","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/ajt.15220","article-title":"Influence of epidemiology, immunosuppressive regimens, clinical presentation, and treatment on kidney transplant outcomes of patients diagnosed with tuberculosis: a retrospective cohort analysis","volume":"19","author":"Viana","year":"2019","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jfma.2023.04.025_bib44","series-title":"Taiwan guidelines for TB diagnosis and treatment","author":"Chiang","year":"2022"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.025_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00003088-199222010-00005","article-title":"Pharmacokinetic drug interactions with rifampicin","volume":"22","author":"Venkatesan","year":"1992","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.025_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clpt.2005.03.004","article-title":"Drug interaction between mycophenolate mofetil and rifampin: possible induction of uridine diphosphate-glucuronosyltransferase","volume":"78","author":"Kuypers","year":"2005","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.jfma.2023.04.025_bib47","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4212\/cjhp.v66i6.1313","article-title":"Decreased tacrolimus levels after administration of rifampin to a patient with renal transplant","volume":"66","author":"Naylor","year":"2013","journal-title":"Can J Hosp Pharm"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.025_bib48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1345\/aph.19069","article-title":"Renal allograft dysfunction associated with rifampin-tacrolimus interaction","volume":"34","author":"Chenhsu","year":"2000","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.jfma.2023.04.025_bib49","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s12185-010-0535-7","article-title":"Overcoming the effect of rifampin on the tacrolimus metabolism by itraconazole administration in an allogeneic hematopoietic stem cell transplant recipient","volume":"91","author":"Mori","year":"2010","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.025_bib50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/0971-4065.62091","article-title":"Mycophenolic acid area under the curve recovery time following rifampicin withdrawal","volume":"20","author":"Annapandian","year":"2010","journal-title":"Indian J Nephrol"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.025_bib51","first-page":"112","article-title":"Drug interaction between rifampicin and sirolimus in transplant patients","volume":"22","author":"Ngo","year":"2011","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"6","key":"10.1016\/j.jfma.2023.04.025_bib52","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1345\/aph.1A384","article-title":"Effect of rifampin on apparent clearance of everolimus","volume":"36","author":"Kovarik","year":"2002","journal-title":"Ann Pharmacother"},{"issue":"9","key":"10.1016\/j.jfma.2023.04.025_bib53","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/00007890-199705150-00015","article-title":"Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain","volume":"63","author":"Aguado","year":"1997","journal-title":"Transplantation"},{"issue":"6369","key":"10.1016\/j.jfma.2023.04.025_bib54","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/bmj.286.6369.923","article-title":"Rifampicin reduces effectiveness and bioavailability of prednisolone","volume":"286","author":"McAllister","year":"1983","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.jfma.2023.04.025_bib55","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00315399","article-title":"Time course of the changes in prednisolone pharmacokinetics after co-administration or discontinuation of rifampin","volume":"45","author":"Lee","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jfma.2023.04.025_bib56","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200140050-00002","article-title":"Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials","volume":"40","author":"Burman","year":"2001","journal-title":"Clin Pharmacokinet"},{"issue":"6 Suppl 2","key":"10.1016\/j.jfma.2023.04.025_bib57","article-title":"Comparative analysis of the drug-drug interaction between immunosuppressants, safety and efficacy of rifabutin from rifampicin-based Anti-TB treatment in living donor liver transplant recipients with active tuberculosis","volume":"44","author":"Wang","year":"2021","journal-title":"Biomed J"},{"issue":"4","key":"10.1016\/j.jfma.2023.04.025_bib58","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/S0272-6386(04)00947-3","article-title":"Treatment of tuberculosis with rifabutin in a renal transplant recipient","volume":"44","author":"L\u00f3pez-Montes","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.jfma.2023.04.025_bib59","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13471","article-title":"Rifabutin for treating tuberculosis in solid organ transplant recipients: a retrospective observational study and literature review","volume":"23","author":"Gomila-Grange","year":"2021","journal-title":"Transpl Infect Dis"},{"issue":"10","key":"10.1016\/j.jfma.2023.04.025_bib60","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0090-9556(25)08417-X","article-title":"Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human","volume":"24","author":"McLellan","year":"1996","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.025_bib61","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/106002809402800117","article-title":"Does ciprofloxacin interact with cyclosporine?","volume":"28","author":"Hoey","year":"1994","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.025_bib62","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/j.1552-4604.1998.tb04382.x","article-title":"Levofloxacin does not alter cyclosporine disposition","volume":"38","author":"Doose","year":"1998","journal-title":"J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.jfma.2023.04.025_bib63","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13513","volume":"33","author":"Subramanian","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jfma.2023.04.025_bib64","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","article-title":"Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis","volume":"167","author":"Yee","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jfma.2023.04.025_bib65","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0041-3879(82)80018-4","article-title":"Adverse effects of antituberculosis drugs causing changes in treatment","volume":"63","author":"Gonzalez Montaner","year":"1982","journal-title":"Tubercle"},{"key":"10.1016\/j.jfma.2023.04.025_bib66","series-title":"Treatment of tuberculosis: guidelines for national programmes","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.jfma.2023.04.025_bib67","series-title":"Taiwan tuberculosis control report 2020","author":"Taiwan Centers for Disease Control","year":"2021"},{"issue":"8","key":"10.1016\/j.jfma.2023.04.025_bib68","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.transproceed.2008.08.013","article-title":"Tuberculosis after heart transplantation: twenty years of experience in a single center in taiwan","volume":"40","author":"Chou","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jfma.2023.04.025_bib69","doi-asserted-by":"crossref","first-page":"733","DOI":"10.12659\/AOT.911034","article-title":"Clinical outcomes of tuberculosis in recipients after living donor liver transplantation","volume":"23","author":"Salvador","year":"2018","journal-title":"Ann Transpl"},{"issue":"2","key":"10.1016\/j.jfma.2023.04.025_bib70","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jmii.2019.08.006","article-title":"Risk factors of tuberculosis after liver transplant in a tertiary care hospital","volume":"54","author":"Leong","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"10.1016\/j.jfma.2023.04.025_bib71","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.transproceed.2013.10.051","article-title":"A nationwide population-based study of the risk of tuberculosis in different solid organ transplantations in taiwan","volume":"46","author":"Chen","year":"2014","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jfma.2023.04.025_bib72","series-title":"WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment","author":"World Health Organization","year":"2020"},{"issue":"4S1","key":"10.1016\/j.jfma.2023.04.025_bib73","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/TP.0000000000003136","article-title":"KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation","volume":"104","author":"Chadban","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.jfma.2023.04.025_bib74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/1469-0691.12641","article-title":"Mycobacterial infections in solid organ transplant recipients","volume":"20","author":"Meije","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jfma.2023.04.025_bib75","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"Treatment of tuberculosis","volume":"167","author":"American Thoracic Society, Centers for Disease Control and Prevention, Infectious Disease Society of America","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.025_bib76","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200402-179OC","article-title":"Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens","volume":"170","author":"Mori","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.jfma.2023.04.025_bib77","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.201405-0967OC","article-title":"Risk assessment of tuberculosis in immunocompromised patients. A TBNET study","volume":"190","author":"Sester","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.025_bib78","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.kint.2016.01.034","article-title":"Tuberculosis and chronic kidney disease: an emerging global syndemic","volume":"90","author":"Romanowski","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2023.04.025_bib79","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/cid\/ciz851","article-title":"Latent tuberculosis infection increases in kidney transplantation recipients compared with transplantation candidates: a neglected perspective in tuberculosis control","volume":"71","author":"Shu","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jfma.2023.04.025_bib80","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1086\/599035","article-title":"Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort","volume":"48","author":"Torre-Cisneros","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"22","key":"10.1016\/j.jfma.2023.04.025_bib81","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection","volume":"372","author":"Getahun","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jfma.2023.04.025_bib82","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/jac\/dku562","article-title":"Isoniazid treatment to prevent TB in kidney and pancreas transplant recipients based on an interferon-\u03b3-releasing assay: an exploratory randomized controlled trial","volume":"70","author":"Kim","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.jfma.2023.04.025_bib83","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13178","article-title":"Treatment of latent TB Infection and the risk of tuberculosis after solid organ transplantation: comprehensive review","volume":"21","author":"Abad","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jfma.2023.04.025_bib84","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.med.46.1.47","article-title":"The changing face of tuberculosis","volume":"46","author":"Huebner","year":"1995","journal-title":"Annu Rev Med"},{"issue":"2","key":"10.1016\/j.jfma.2023.04.025_bib85","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1034\/j.1399-3062.1999.010203.x","article-title":"Tuberculosis in renal transplant recipients","volume":"1","author":"Lattes","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jfma.2023.04.025_bib86","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1164\/ajrccm.154.5.8912765","article-title":"Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis","volume":"154","author":"McGregor","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.jfma.2023.04.025_bib87","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1111\/j.1432-2277.2012.01561.x","article-title":"Management of rifamycins-everolimus drug-drug interactions in a liver-transplant patient with pulmonary tuberculosis","volume":"25","author":"Lefeuvre","year":"2012","journal-title":"Transpl Int"},{"issue":"5","key":"10.1016\/j.jfma.2023.04.025_bib88","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000166968","article-title":"Low cyclosporin A blood levels and acute graft rejection in a renal transplant recipient during rifampin treatment","volume":"5","author":"Offermann","year":"1985","journal-title":"Am J Nephrol"},{"issue":"2","key":"10.1016\/j.jfma.2023.04.025_bib89","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000183583","article-title":"Effect of rifampicin on cyclosporin A blood levels in a renal transplant recipient","volume":"41","author":"Cassidy","year":"1985","journal-title":"Nephron"},{"issue":"17","key":"10.1016\/j.jfma.2023.04.025_bib90","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.1976.03270180034016","article-title":"Interaction of rifampin and glucocorticoids: adverse effect on renal allograft function","volume":"236","author":"Buffington","year":"1976","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.025_bib91","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/lt.25654","article-title":"Tuberculosis treatment with a 3-drug rifamycin-free regimen in liver transplant recipients","volume":"26","author":"Sullivan","year":"2020","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jfma.2023.04.025_bib92","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.5588\/ijtld.16.0945","article-title":"Tuberculosis in recipients of solid-organ transplants during 1995-2015 in cali, Colombia. [Erratum appears in: int J tuberc lung dis 2018;22:354","volume":"21","author":"Garc\u00eda-Goez","year":"2017","journal-title":"Int J Tubercul Lung Dis"},{"issue":"4","key":"10.1016\/j.jfma.2023.04.025_bib93","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000013600","article-title":"Diagnosis and treatment of tuberculosis in hemodialysis and renal transplant patients","volume":"20","author":"Vachharajani","year":"2000","journal-title":"Am J Nephrol"},{"issue":"4","key":"10.1016\/j.jfma.2023.04.025_bib94","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00007890-199010000-00014","article-title":"Successful use of rifampicin in the treatment of tuberculosis in renal transplant patients immunosuppressed with cyclosporine","volume":"50","author":"al-Sulaiman","year":"1990","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.jfma.2023.04.025_bib95","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13566","article-title":"Risk factors and clinical outcomes of tuberculosis among kidney transplant recipients in high endemic country","volume":"23","author":"Thitisuriyarax","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jfma.2023.04.025_bib96","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1183\/09031936.00033010","article-title":"Treatment of tuberculosis: update 2010","volume":"37","author":"Yew","year":"2011","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jfma.2023.04.025_bib97","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12672","article-title":"Multidrug-resistant tuberculosis in transplant recipients: case report and review of the literature","volume":"19","author":"Huaman","year":"2017","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.jfma.2023.04.025_bib98","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13659","article-title":"A case series of multidrug-resistant tuberculosis in renal transplant recipients: challenges in management from a TB endemic country","volume":"23","author":"Babar","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jfma.2023.04.025_bib99","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/ajt.15220","article-title":"Influence of epidemiology, immunosuppressive regimens, clinical presentation, and treatment on kidney transplant outcomes of patients diagnosed with tuberculosis: a\u00a0retrospective cohort analysis","volume":"19","author":"Viana","year":"2019","journal-title":"Am J Transpl"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623001511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623001511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:50:15Z","timestamp":1760539815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664623001511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":99,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0929664623001511"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2023.04.025","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention and management of tuberculosis in solid organ transplantation: A consensus statement of the transplantation society of Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2023.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}